CHECKOUT
Step 1/4
DXCM
DexCom
  • Vol:
 

DexCom (DXCM)

.

DexCom (DXCM) - Develops continuous glucose monitoring systems for ambulatory use by patients with diabetes

 GROUP LEADERSHIP
Medical-Products Group
DXCM
is ranked
#2
2nd in group
is ranked
#1
1st in group
 IBD RATINGS FOR DXCM
  • Checklist
  • Rating

Take a Free Trial to see all ratings

DXCM NEWS
  • DXCM NEWS FROM IBD
  • DXCM NEWS - IBD PARTNERS
IBD

Dow Jones Futures: Microsoft, Google Jump; New Market Rally Still Must Do This

Best Growth Stocks To Buy And Watch: See Updates To IBD Watchlists

Cava, Chipotle Among 11 Stocks In Spotlight. Check Out IBD Lists For Stocks To Buy And Watch. 

Dexcom Plummets After Raising Its Sales Guidance For The Year — But Not Enough

Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating

View All »

IBD Partners
No News Available.
 STOCK/COMPANY DATA FOR DXCM
    Stock Data
  • Today's Range
  • 134.39  -  139.24
  • 52-Week Range
  • 74.75  -  142.00
  • Price % Chg. YTD
  • 11.22%
  • Price % Chg. Last 4 Weeks
  • -0.66%
  • 50-Day Avg. Volume
  • 3,063,800
  • Shares Outstanding
  • 385.5 Mil
  • Float
  • 381.7 Mil
  • IPO Date
  • 04/14/2005
  • Investment Bank
  • Canaccord Capital Cp
  • % Mgmt Owns
  • 1%
  • PE Ratio
  • 83
  • Dividend Yield
  • 0
  • Alpha
  • -0.01
  • Beta
  • 0.92
    Company Fundamentals
  • EPS Due Date
  • 7/25/2024
  • EPS % Chg (Last Qtr)
  • 88%
  • 3 Year EPS Growth Rate
  • 40%
  • EPS Est % Chg (Current Yr)
  • 17%
  • Annual ROE
  • 29.2%
  • Sales % Chg (Last Qtr)
  • 24%
  • 3-Year Sales Growth Rate
  • 22%
  • Debt %
  • 118%
  • Market Cap
  • $53.2 B $53 Bil
  • Annual Pre -Tax Margin
  • 22.9%
  • Sector
  • medical
  • Industry Group
  • Medical-Products
  • Industry Group Rank
  • 48